Investor Relations

Stock Information

Symbol

Nasdaq: VTGN

Price

Change

Volume

52 week Low/High

Day Low/High

Company Overview

VistaGen Therapeutics is a clinical-stage biopharmaceutical company developing new generation medicines for anxiety, depression and other CNS disorders where the current standard of care is inadequate, resulting in high unmet need. Each of VistaGen's three drug candidates, PH94B, PH10, and AV-101, has a differentiated mechanism of action, an exceptional safety profile in all studies to date, and therapeutic potential in multiple CNS markets.

Contact Information

VistaGen Therapeutics, Inc.
Mark A. McPartland
Vice President, Corporate Development and Investor Relations
(650) 577-3606
markmcp@vistagen.com

Transfer Agent
Computershare, Inc.
P.O. BOX 30170
College Station, TX 77842
(800) 368-5948
www-us.computershare.com